Zobrazeno 1 - 10
of 36
pro vyhledávání: '"E. E. Eldering"'
Autor:
Timon A. Bloedjes, E. E. Eldering, Marcel Spaargaren, G. de Wilde, Jeroen E. J. Guikema, C. J. M. Van Noesel, Chiel Maas, Richard J. Bende, S. T. Pals
The phosphatidylinositide-3 kinases (PI3K) and the downstream mediator AKT drive survival and proliferation of multiple myeloma (MM) cells and several AKT inhibitors are currently being tested in clinical trials for MM patients. AKT inhibition has pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76d8f9f4e66d8a4d0de1e116d0122f7
https://doi.org/10.1101/816694
https://doi.org/10.1101/816694
Autor:
Kielbassa K; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute (AIII), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands., Van der Weele L; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute (AIII), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. l.vanderweele@amsterdamumc.nl.; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Centre (ARC), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. l.vanderweele@amsterdamumc.nl., Voskuyl AE; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Centre (ARC), Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands., de Vries N; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute (AIII), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Centre (ARC), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Eldering E; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute (AIII), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands., Kuijpers TW; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Arthritis research & therapy [Arthritis Res Ther] 2023 Nov 22; Vol. 25 (1), pp. 225. Date of Electronic Publication: 2023 Nov 22.
Autor:
Slinger E; Cancer Center Amsterdam, Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Thijssen R; Cancer Center Amsterdam, Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Kater AP; Cancer Center Amsterdam, Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands., Eldering E; Cancer Center Amsterdam, Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Publikováno v:
Leukemia [Leukemia] 2017 Dec; Vol. 31 (12), pp. 2601-2607. Date of Electronic Publication: 2017 May 02.
Autor:
van Attekum MHA; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Terpstra S; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Slinger E; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., von Lindern M; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands., Moerland PD; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Jongejan A; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kater AP; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands., Eldering E; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Publikováno v:
Oncogene [Oncogene] 2017 Jun 29; Vol. 36 (26), pp. 3651-3660. Date of Electronic Publication: 2017 Feb 13.
Autor:
Thijssen R, Ter Burg J, van Bochove GG, de Rooij MF, Kuil A, Jansen MH, Kuijpers TW, Baars JW, Virone-Oddos A, Spaargaren M, Egile C, van Oers MH, Eldering E, Kersten MJ, Kater AP
Publikováno v:
Leukemia [Leukemia] 2016 Sep; Vol. 30 (9), pp. 1963.
Autor:
van Attekum MH; Department of Hematology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam.; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam., Kater AP; Department of Hematology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam., Eldering E; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam.
Publikováno v:
Cell death & disease [Cell Death Dis] 2016 Jun 23; Vol. 7 (6), pp. e2276. Date of Electronic Publication: 2016 Jun 23.
Autor:
van Attekum M; Academic Medical Center, Department of Hematology, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands; Academic Medical Center, Department of Experimental Immunology, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Terpstra S; Academic Medical Center, Department of Hematology, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands; Academic Medical Center, Department of Experimental Immunology, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Reinen E; Academic Medical Center, Department of Hematology, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands; Academic Medical Center, Department of Experimental Immunology, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Kater AP; Academic Medical Center, Department of Hematology, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Eldering E; Academic Medical Center, Department of Experimental Immunology, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Publikováno v:
Cell death discovery [Cell Death Discov] 2016 Mar 21; Vol. 2, pp. 16020. Date of Electronic Publication: 2016 Mar 21 (Print Publication: 2016).
Autor:
te Raa GD; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Moerland PD; Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands., Leeksma AC; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Derks IA; Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Yigittop H; MRC-Holland, Amsterdam, The Netherlands., Laddach N; MRC-Holland, Amsterdam, The Netherlands., Loden-van Straaten M; MRC-Holland, Amsterdam, The Netherlands., Navrkalova V; Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Trbusek M; Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Luijks DM; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Zenz T; Department of Translational Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ) and Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Skowronska A; School of Cancer Sciences, University of Birmingham, Birmingham, UK., Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Stankovic T; School of Cancer Sciences, University of Birmingham, Birmingham, UK., van Oers MH; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] LYMMCARE (Lymphoma and Myeloma Center), Amsterdam, The Netherlands., Eldering E; 1] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands [2] LYMMCARE (Lymphoma and Myeloma Center), Amsterdam, The Netherlands., Kater AP; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Laboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands [3] LYMMCARE (Lymphoma and Myeloma Center), Amsterdam, The Netherlands.
Publikováno v:
Cell death & disease [Cell Death Dis] 2015 Aug 06; Vol. 6, pp. e1852. Date of Electronic Publication: 2015 Aug 06.
Autor:
Spaargaren M; 1] Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands [2] Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Academic Medical Center, Amsterdam, The Netherlands., de Rooij MF; Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kater AP; 1] Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Academic Medical Center, Amsterdam, The Netherlands [2] Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Eldering E; 1] Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Academic Medical Center, Amsterdam, The Netherlands [2] Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Oncogene [Oncogene] 2015 May 07; Vol. 34 (19), pp. 2426-36. Date of Electronic Publication: 2014 Jun 23.
Autor:
Te Raa GD; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Derks IA; Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Navrkalova V; Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Skowronska A; School of Cancer Sciences, University of Birmingham, Birmingham, UK., Moerland PD; Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands., van Laar J; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Oldreive C; School of Cancer Sciences, University of Birmingham, Birmingham, UK., Monsuur H; Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Trbusek M; Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Malcikova J; Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Lodén M; MRC-Holland, Amsterdam, The Netherlands., Geisler CH; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Hüllein J; Department of Translational Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany., Jethwa A; Department of Translational Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany., Zenz T; 1] Department of Translational Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany [2] Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Pospisilova S; Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Stankovic T; School of Cancer Sciences, University of Birmingham, Birmingham, UK., van Oers MH; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands., Kater AP; 1] Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands [2] Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands., Eldering E; 1] Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands [2] Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Publikováno v:
Leukemia [Leukemia] 2015 May; Vol. 29 (5), pp. 1133-42. Date of Electronic Publication: 2014 Nov 05.